http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104109120-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7826e82a59639f553bfb024dfb2a0ea5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fb48fdbfe8979c66e84a811efd9086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2521f93eb2190d62f39e795d4b5ef096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b1075a216b9d0e6b4c07394a0a4f84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed449170aee7ad511db9c63778a34f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50c76e6ceb137365333c09e213bb26d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd59544a300d18b18cb629e1c101d11e
publicationDate 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104109120-A
titleOfInvention N'-Aroyl o-pyridine hydrazide derivatives and its preparation method, pharmaceutical composition and application
abstract The invention discloses N′-aryl acryloyl o-pyridine hydrazide derivatives represented by formula I, their pharmaceutically acceptable salts, their preparation methods, compositions containing one or more of these compounds, and the use of such compounds in the treatment of Use in diseases related to protein kinases, such as immune disorders and tumor diseases.
priorityDate 2013-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101381379-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008115263-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004078128-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87056786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163770288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464999353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10151557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465180773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465456633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430851428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465351947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87056705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87056863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422463817

Total number of triples: 41.